BioSpace News Archive

Medifast, Inc . (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Dan Chard , Chairman and Chief Executive Officer, and Jim Maloney , Chief Financial Officer, will present at the 23rd Annual ICR Conference on Monday, January 11, 2021 virtually.

U.S. Renal Care (USRC), a leading provider of dialysis services caring for more than 26,000 individuals living with kidney disease, announced it will obtain and distribute the monoclonal antibody therapy, Bamlan

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced today it has received guidance from the U.S Food & Drug Administration (“FDA”) regarding the impact of COVID-19 on its Phase III clinical tri

The following quote is attributed to Jeffrey Shuren M.D ., J.D., director of FDA’s Center for Devices and Radiological Health: “Providing women with access to safe medical devices to meet their health care needs is a top priority for the FDA. Today, we’ve taken two important steps on laparoscopic power morcellators as a

CYduct Diagnostics, Inc. (OTC PINK:SNDYD) is pleased to announce that FINRA has approved a change in the Company’s stock symbol trading on the OTC Markets. Effective tomorrow, December 30, 2020, the Company’s common shares will trade on the OTC Markets under the symbol “CYDX.”

Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that R.J. Smith, a seasoned leader in the orthopedic and medical device industry, has joined the company in the newly created role as Vice President of Customer Experience

CVS Health Corporation (NYSE: CVS) today announced that President and Chief Executive Officer Larry Merlo, Executive Vice President and Chief Financial Officer Eva Boratto, and Executive Vice President and President, Aetna Karen Lynch, will participate in a fireside chat with investors at the J.P. Morgan 39th Annual Healthcare Conference

2020 marks record year in new program signings as interactive data solutions help long-term care providers proactively improve clinical outcomes and uncover revenue opportunities

Emergent BioSolutions (NYSE: EBS) and Mount Sinai Health System today announced initiation of the clinical program to evaluate Emergent’s COVID-19 Human Hyperimmune Globulin (COVID-HIG) product candidate in the first of two Phase 1 studies to support its use for potential post-exposure prophylaxis in individuals at high risk of exposure to SARS-CoV-2,

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 23rd Annual Needham Virtual Growth Conference at 1:15 p.m. ET on Monday, January 11, 2021.